The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.

[1]  S. Pileri,et al.  Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. , 2010, Blood.

[2]  B. Ozanne,et al.  CD23/FcεRII: molecular multi‐tasking , 2010, Clinical and experimental immunology.

[3]  J. Minárovits,et al.  Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. , 2009, The Journal of general virology.

[4]  J. Minárovits,et al.  Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. , 2008, The Journal of general virology.

[5]  J. Minárovits,et al.  Acetylated Histone H3 and H4 Mark the Upregulated LMP2A Promoter of Epstein-Barr Virus in Lymphoid Cells , 2007, Journal of Virology.

[6]  W. Lucchesi,et al.  Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. , 2006, The Journal of general virology.

[7]  S. Pileri,et al.  Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. , 2005, Blood.

[8]  J. Minárovits,et al.  Epigenetic regulation of lymphoid specific gene sets. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[9]  L. Verdone,et al.  Role of histone acetylation in the control of gene expression. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  P. Lieberman,et al.  Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus , 2004, Journal of Virology.

[11]  J. Minárovits,et al.  High-resolution Methylation Analysis and In Vivo Protein–DNA Binding at the Promoter of the Viral Oncogene LMP2A in B Cell Lines Carrying Latent Epstein–Barr Virus Genomes , 2003, Virus Genes.

[12]  H. Gruffat,et al.  Differential Hyperacetylation of Histones H3 and H4 upon Promoter-Specific Recruitment of EBNA2 in Epstein-Barr Virus Chromatin , 2003, Journal of Virology.

[13]  B. Ozanne,et al.  The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes , 2002, Genes and Immunity.

[14]  A. Rickinson.  Epstein-Barr virus. , 2001, Virus research.

[15]  J. Minárovits,et al.  Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus , 2001, Journal of Virology.

[16]  J. Minárovits,et al.  Epigenetics of Latent Epstein-Barr Virus Genomes: High Resolution Methylation Analysis of the Bidirectional Promoter Region of Latent Membrane Protein 1 and 2B Genes , 2001, Biological chemistry.

[17]  J. Hsieh,et al.  A Role for SKIP in EBNA2 Activation of CBF1-Repressed Promoters , 2000, Journal of Virology.

[18]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Hsieh,et al.  CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Lacy,et al.  Regulation of the human IgE receptor (Fc epsilonRII/CD23) by Epstein-Barr virus (EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23. , 1997, International immunology.

[21]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[22]  J. Hsieh,et al.  Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. , 1995, Science.

[23]  J. Lacy,et al.  Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors. , 1994, Journal of Immunology.

[24]  L. Strobl,et al.  Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element , 1994, Journal of virology.

[25]  J. Hsieh,et al.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1 , 1994, Journal of virology.

[26]  J. Lacy,et al.  Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1. , 1992, Journal of immunology.

[27]  I. Ernberg,et al.  Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Kieff,et al.  Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 , 1990, Journal of virology.

[29]  G. Texidó,et al.  Expression of human lymphocyte IgE receptor (Fc epsilon RII/CD23). Identification of the Fc epsilon RIIa promoter and its functional analysis in B lymphocytes. , 1989, Journal of immunology.

[30]  H. Kikutani,et al.  Two species of human Fcε receptor II ( FcεRII CD23 ): Tissue-specific and IL-4-specific regulation of gene expression , 1988, Cell.

[31]  B. Barrell,et al.  Sequence analysis of Raji Epstein-Barr virus DNA. , 1988, Virology.

[32]  R. Bastos,et al.  Molecular structure of the gene and the 5'-flanking region of the human lymphocyte immunoglobulin E receptor. , 1987, Nucleic acids research.

[33]  S. Swendeman,et al.  The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.

[34]  D. Thorley-Lawson,et al.  Early events in Epstein-Barr virus infection provide a model for B cell activation , 1985, The Journal of experimental medicine.

[35]  R. Schooley,et al.  BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. , 1985, Journal of immunology.

[36]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.

[37]  B. Griffin,et al.  The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non‐transforming strain (P3HR‐1) of the virus. , 1984, The EMBO journal.